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ABSTRACT
Objective: The purpose of this study was to evaluate the synergistic and efflux pump inhibitory activities of some important medicinal plants collected 
from Western Himalaya against different strains of Staphylococcus aureus to facilitate the reintroduction of therapeutically ineffective antibiotics back 
into clinical use.
Methods: Various plant materials were extracted using methanol, ethyl acetate, and water. The dried extracts were screened for synergistic activity 
by well diffusion method, and efflux pump inhibitory activity for plants extracts exhibiting maximum synergism assessed by berberine uptake assay 
and ethidium bromide efflux inhibition assay, respectively.
Results: Methanolic extract (ME) and ethyl acetate extracts (EE) of most of the plant extracts showed synergistic activity with ciprofloxacin and 
norfloxacin, whereas an aqueous extract showed no any synergistic activity. Maximum efflux pump inhibitory activity was observed for ME of Angelica 
glauca followed by EE of Ficus carica.
Conclusion: ME of A. glauca exhibited potentials of efflux pump inhibition, and thus can, be used as an adjuvant with antibiotics to overcome the 
problem of drug resistance due to efflux.
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INTRODUCTION
Staphylococcus aureus is a considerable concern pathogen in both 
community and hospital settings as it causes mild to severe life-
threatening infections [1]. Besides, its virulence it also shows a 
remarkable diversity of resistance [2]. Unfortunately, every new 
antibiotic developed to treat S. aureus infections has been accompanied 
by bacterial antibiotic resistance [3]. Antibiotic resistance is developed 
by prescribed drug regime’s failure and human errors [4]. Numerous 
defense mechanisms providing resistance to bacteria against the 
antibiotics include target site modification, antibiotic inactivation, and 
reduction of the intracellular concentration of the antibiotic, either by a 
decreased permeability of the cell wall or by the efflux of antibiotic [5]. 
All known mechanisms of drug resistance are overshadowed by efflux-
mediated resistance. Bacterial efflux pumps can be specific, extruding 
only one antibiotic or class of antibiotics, or be capable of extruding 
several classes of antimicrobial compounds [6]. For Gram-positive 
bacteria, pumps belonging to the major facilitator superfamily (MFS) play 
a key role in the efflux [7]. NorA multi-drug resistance pump (member 
of MFS) of S. aureus is predominant, chromosomally encoded and can 
efflux fluoroquinolones, quaternary ammonium compounds, ethidium 
bromide, rhodamine, and acridines [8]. Reversal of antibiotic resistance 
or clinical performance of antibiotics can be improved by employing 
efflux pump inhibitors [9]. The use of plants for treating diseases is as old 
as the human species. Use and efficacy of medicinal plants significantly 
contribute to the disclosure of their therapeutic properties [10,11]. 
Plants are natural resources of important phytoconstituents and have 
been explored as potential sources of antimicrobials. This raises the 
prospects of obtaining novel chemotherapeutic compounds, especially 
efflux pump inhibitors. A number of new chemical compounds based 
on their NorA efflux pump inhibition properties have been investigated, 
but none of the efflux pump inhibitors have entered clinical trials 
due to their pharmacokinetic properties and toxic effects. The new 
active compounds present in medicinal plants give new hope for their 
future therapeutic usage as an adjuvant of antibiotic [12]. Thus, to 
overcome the problem of drug resistance due to efflux of ciprofloxacin 
and norfloxacin, mediated by NorA pump of S. aureus, this study was 
conducted.
METHODS
Collection of plant materials
The roots, leaves, flowers, and rhizomes of 11 medicinal plants, namely, 
Angelica glauca, Berberis aristata, Dactylorhiza hatagirea, Ficus carica, 
Girardinia diversifolia, Malva neglecta, Sinopodophyllum hexandrum, 
Rubia cordifolia, Sedum glaucophyllum, Solanum americanum, and 
Valeriana jatamansi were collected from Bhanara, Kullu, Himachal 
Pradesh, India of North Western Himalaya. The plants specimens have 
been duly identified and deposited in the herbarium of Botanical Survey 
of India, Northern circle, Dehradun, Uttarakhand, India.
Processing of plant materials
Plant materials were washed with distilled water and roots were cut 
into small bits to facilitate drying. Subsequently, the plant materials 
were allowed to air dry and grinded into fine powder. The powdered 
samples were stored in clean glassware containers under refrigerated 
condition until subjected to further analysis.
Extraction of plant materials
The each plant material was extracted with methanol (70%), ethyl acetate 
(70%) and distilled water. 10 g of plant material was soaked in 100 ml of 
each solvent for 4 days with shaking at the Orbital Rotary Shaker. The 
extract was clarified by filtration through Whatman filter paper number 
1 and concentrated using a water bath at 40°C for 12 hrs [13].
Bacterial strains tested
S. aureus 8325-4 (wild type), K1758 (NorA knockout), and K2378 (NorA 
overexpressing) were obtained from Northeastern University, Boston, 
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USA inoculated in glycerol stocks and maintained on mannitol salt agar 
plates at Microbiology Research Laboratory Shoolini University, Solan, 
Himachal Pradesh, India.
Antibiotics used
Norfloxacin and ciprofloxacin antibiotics which are effluxed by NorA 
pump of S. aureus were obtained from Sisco Research Laboratories (P) 
Ltd. and Himedia Laboratories, India, respectively.
Well diffusion method
The well diffusion assay was performed according to the National 
Committee for Clinical Laboratory Standards. Mueller-Hinton agar 
plates were seeded with a 24 hrs culture of the bacterial strains and 
inoculum was adjusted to an optical disc (OD) of 0.8 abs. Wells of 
6 mm diameter were punched in the agar, and plant extracts (PE) and 
antibiotics were added in a concentration of 100 mg/ml and 5 µg, 
respectively. Plates were incubated at 37°C for 24 hrs. For strain where 
antibiotic did not showed any inhibition zone alone, the combination 
of PE with antibiotic was calculated on the basis of growth inhibitory 
indices (GIIs) values and the combination was considered as synergistic, 
additive and antagonistic when GIIs >1, 1 and <1, respectively, whereas 
antibiotic showing inhibition alone and in combination, synergistic, 
additive, and antagonistic activities of PEs with antibiotics were defined 
with GIIs >0.5, 0.5, and <0.5, respectively [14].
GIIs 
Zone of inhibition in combination antibiotic  plant
=
+  extract
Total of zone of inhibition alone
( )
The method was performed in triplicates. After screening for synergistic 
activity, plants showing maximum synergistic activity were taken for 
further study.
Screening of efflux pump inhibitory activity
Berberine uptake assay
Berberine uptake assay was performed for the isolation of efflux pump 
inhibitors [15]. Serial two-fold dilutions of berberine and a PE were 
mixed in each well of a 96 well microtiter plate. Each row (and column) 
contained a fixed amount of one agent and increasing amounts of the 
second agent. The concentrations of berberine (row) ranged from 30 to 
0.5 µg/ml (89-1.5 µM), while plant compound (column) concentrations 
ranged from 15 to 0.015 µg/ml. Inoculums were added to each well at 
a final concentration of 5 × 106 CFU/mL, and plates were incubated at 
37°C for 24 hrs. Growth was assayed by absorption at 600 nm with a 
microtiter plate reader. An OD <0.04 abs was considered to reveal no 
bacterial growth. Three replicates were performed for the same.
Ethidium bromide efflux inhibition assay
Accumulation of ethidium bromide was assessed by ethidium bromide 
efflux inhibition assay [16]. Sterile microtitre plates were used for this 
assay. The bacterial inoculum of 175 µl was added to each well of 96 
well microtiter plates. The 10 µl of tested compound added to columns 
1-10. 30 µl of 100 µM EtBr was added to each well. Accordingly, 10 µl of 
positive control (chlorophenylhydrazone) added to column 11. 10 µl of 
negative control (dimethyl sulfoxide) also added to column 12. Plates 
were immediately placed in fluoroscan ascent Fl and fluorescence of the 
accumulated ethidium bromide for 30 minutes at excitation (530 nm) 
and emission (600 nm) were determined. Three replicates were 
performed for each analysis.
RESULTS
In the present investigation, different extracts (aqueous, ethyl acetate 
and methanolic) of plants were evaluated for exploration of efflux 
pump inhibitory activity against S. aureus strains. Synergistic activity of 
each PE with antibiotics (ciprofloxacin and norfloxacin) was evaluated 
by well diffusion method and efflux pump inhibition for effective plants 
was assessed by berberine uptake assay and ethidium bromide efflux 
inhibition assay.
The results of the conducted experiments demonstrated that the most 
of tested PEs contain potential synergistic activity with antibiotics 
against S. aureus strains; while, aqueous extract of all plants and 
methanolic extract (ME) and ethyl acetate extract (EE) of B. aristata and 
S. americanum showed no more synergistic activity.
For NorA overexpressing strain 2378, the antibiotic revealed no any 
inhibition zone alone. Results given in Table 1 showed that all the ME 
and EEs of plants showed synergism (GIIs >1). ME of A. glauca and 
V. jatamansi showed maximum (GII=1.55) and minimum (GII=1.04) 
synergistic activities, respectively. For S. aureus 8325-4 and K1758 
strains, an antibiotic showed inhibition alone and as well as in 
combination. The results (Table 1) showed that for NorA wild-type 
strain, the GIIs values of ciprofloxacin with PEs in combination ranged 
from 0.60 to 0.75. Maximum synergism was shown by ME of Sedum 
glaucophylum (GII=0.75).
In the other hand, the 1758 strain showed the maximum synergism 
with highest GII value (0.67) with a combination of ciprofloxacin with 
ME of S. glaucophylum and minimum synergism with lowest GII value 
(0.44) was shown by EE of D. hatagirea (Table 1).
GII values for norfloxacin in combination with PEs ranged from 0.50 to 
1.50 (Table 2). Maximum synergism was shown by EE of V. jatamansi 
(GII=1.50) against K2378 strain, while EE of S. hexandrum showed 
maximum synergism against 8325-4 strain. In K1758 strain GII values 
ranged from 0.50 to 0.63 for all tested PEs.
On the basis of synergistic activities of six PEs, namely, V. jatamansi 
(EE), S. glaucophyllum (ME), A. glauca (ME), S. hexandrum (EE), 
M. neglecta (EE), and F. carica (EE) which showed maximum synergistic 
activities were selected for efflux pump inhibitory activity. Berberine 
is an efflux pump substrate and inhibits growth of bacteria in the 
presence of efflux pump inhibitor and hence acts as a marker to find out 
efflux pump inhibitors. A fixed concentration of berberine (30 µg/ml 
or 89 µM) and serial two-fold dilution of PEs (15-0.015 µg/ml) were 
used in the investigation. An OD ≤0.04 revealed no bacterial growth. 
The absorbances at different minimum inhibitory concentrations are 
presented in the Fig. 1.
Six PEs chosen on the basis of synergistic activities were also observed 
potent in Berberine uptake assay. Out of six plants, A. glauca (ME) 
showed maximum inhibition of growth followed by F. carica (EE) 
against all tested strains.
In ethidium bromide assay, ethidium bromide is also a substrate of 
efflux pumps and is effluxed by strains having efflux pumps. In the 
presence of efflux pump inhibitors, ethidium bromide gets accumulated 
and showed fluorescence.
In all three test strains, A. glauca was showed maximum accumulation of 
ethidium bromide as well as maximum efflux pump inhibitory activity, 
while S. hexandrum (EE) showed minimum efflux pump inhibition 
(Figs. 2-4).
DISCUSSION
The current study initiated because drug resistance is an increasing 
global concern, and this has been witnessed by increasing resistance 
among the S. aureus population leading to once treatable diseases 
incurable [17-19]. All known drug resistance mechanisms are 
overshadowed by the efflux-mediated resistance [6]. Bacterial 
resistance can be restored by synergistic action of bioactive PEs 
which is a novel concept and could be beneficial [20]. In the present 
investigation, methanolic, ethyl acetate, and aqueous extracts of 12 
medicinal plants were screened for synergistic activity with two 
antibiotics (ciprofloxacin and norfloxacin) against S. aureus strains 
(2378 NorA overexpressing strain, 8325-4 wild-type strain and 1758 
NorA knockout strain). Among the three extracts, ME and EEs were 
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found effective, whereas the aqueous extract not showed any synergistic 
activity. Consequently, in the study present investigations, some plants 
exhibited synergistic activity but the results obtained were variable in 
all the three tested strains and the drugs. G. diversifolia has been found 
to be synergistic enhancer, though it does not have any antimicrobial 
properties by yourself, but when taken concurrently with standard 
antibiotics it enhances the effect of that drug. The plants which showed 
maximum synergism in the present investigation were V. jatamansi (EE), 
S. glaucophyllum (ME), A. glauca (ME), S. hexandrum (EE), M. neglecta 
(EE), and F. carica (EE) and were selected for efflux pump inhibitory 
activity. Earlier, several investigations have reported the antimicrobial 
and synergistic activity of most of the PE such as R. cordifolia, 
Rosamarinus officinalis, Salvia fruticosa, Majorana syriaca, Ocimum 
basilicum, Syzygium aromaticum, Laurus nobilis, and Rosa damascene 
against S. aureus strains [18,21-25] and have been emerging out as 
natural sources of potential resistance modifying agents [17,26-33]. All 
Table 1: Synergistic effect between plants extracts (methanolic and ethyl acetate) with ciprofloxacin (average±SD) by well 
diffusion method
Plants (part used) Type 
of 
extract
Zone of inhibition (mm)
2378 (NorA overexpressing) 8325‑4 (wild Type) 1758 (NorA knockout)
PE PE+Cx Cx GIIs PE PE+Cx Cx GIIs PE PE+Cx Cx GIIs
A. glauca (root) ME 11±0.8 17±0.6 - 155 13±0.5 18±0.5 13±0.9 069 13±1 19±0.5 17±0.9 0.63
EE 12±0.4 16±0.8 - 1.33 13±0.8 17±0.5 13±0.6 0.65 15±0.3 19±0.9 17±0.8 0.59
D. hatagirea (rhizome) ME 12±0.4 16±0.3 - 1.33 14±0.4 18±0.3 14±0.3 0.64 14±0.3 19±0.2 17±0.3 0.61
EE 18±0.3 20±0.4 - 1.11 17±0.2 18±0.3 12±0.2 0.62 29±0.4 21±0.4 19±0.4 0.44
F. carica (leaves) ME 17±0.3 19±0.5 - 1.12 18±0.9 18±0.8 12±0.5 0.60 18±1 22±0.58 19±0.3 0.59
EE 12±0.5 17±1 - 1.42 13±0.3 18±0.8 13±0.6 0.69 13±0.8 20±0.5 18±0.3 0.65
G. diversifolia (leaves) ME 12±0.7 15±0.7 - 1.25 12±0.3 17±0.6 13±0.5 0.68 14±0.3 19±0.3 17±0.3 0.61
EE 11±0.2 12±0.6 - 1.09 16±0.6 18±0.2 14±0.5 0.60 15±0.5 19±0.7 17±0.6 0.59
M. neglecta (leaves) ME 9±0.8 12±0.9 - 1.33 12±0.8 17±0.6 15±0.5 0.63 13±0.4 20±0.4 19±0.5 0.63
EE 13±1 18±1 - 1.38 14±0.7 19±0.9 14±0.6 0.68 14±0.7 21±0.7 18±0.5 0.66
S. hexandrum A ME 13±0.3 15±0.4 - 1.15 14±0.2 17±0.2 13±0.3 0.63 14±0.3 20±0.3 18±0.3 0.63
EE 16±0.2 22±0.2 - 1.38 18±0.3 22±0.2 13±0.3 0.71 16±0.6 21±0.3 17±0.5 0.64
R. cordifolia (leaves) ME 15±0.2 18±0.3 - 1.20 15±0.5 18±0.4 13±0.3 0.64 15±0.5 19±0.5 17±0.4 0.59
EE 15±0.6 18±0.5 - 1.20 15±0.6 17±0.4 12±0.6 0.63 18±0.4 20±0.4 19±0.5 0.54
S. glaucophylum 
(whole plant)
ME 12±0.6 17±0.2 - 1.42 12±0.4 18±0.3 12±0.4 0.75 12±0.3 20±0.4 18±0.2 0.67
EE 16±0.2 17±0.4 - 1.06 16±0.2 19±0.4 14±0.4 0.63 16±0.5 18±0.7 16±0.5 0.56
V. jatamansi (root) ME 23±0.4 24±0.4 - 1.04 21±0.2 22±0.4 13±0.2 0.65 22±0.3 22±0.4 19±0.3 0.54
EE 13±0.5 18±0.3 - 1.38 12±0.3 18±0.3 13±0.4 0.72 13±0.3 19±0.2 17±0.3 0.63
Values given are mean of three replicates±SD. GIIs: Growth inhibitory indices, ME: Methanolic extract, EE: Ethyl acetate extract, PE: Plant extract, Cx: Ciprofloxacin, 
SD: Standard deviation, A. glauca: Angelica glauca, D. hatagirea: Dactylorhiza hatagirea, F. carica: Ficus carica, G. diversifolia: Girardinia diversifolia, M. neglecta: Malva 
neglecta, S. hexandrum: Sinopodophyllum hexandrum, R. cordifolia: Rubia cordifolia, S. glaucophylum: Sedum glaucophylum, V. jatamansi: Valeriana jatamansi
Table 2: Synergistic effect of plants extracts (methanolic and ethyl acetate) with norfloxacin (average±SD) by well diffusion method
Plants (part used) Type of 
extract
Zone of inhibition (mm)
2378 (NorA over 
expressing)
8325‑4 (wild type) 1758 (NorA knockout)
PE PE+Nx Nx GIIs PE PE+Nx Nx GIIs PE PE+Nx Nx GIIs
A. glauca (root) ME 12±0.4 17±0.8 - 1.42 15±0.3 19±0.5 12±1 0.70 14±0.4 19±0.5 17±0.3 0.61
EE 12±0.3 15±0.4 - 1.25 12±0.2 15±0.3 12±0.8 0.63 12±0.4 17±0.5 16±0.5 0.61
D. hatagirea (rhizome) ME 12±0.2 14±0.4 - 1.17 14±0.5 17±0.3 13±0.2 0.63 12±0.4 15±0.3 18±0.3 0.50
EE 12±0.3 15±0.3 - 1.25 13±0.2 15±0.3 12±0.3 0.60 11±0.4 15±0.2 17±0.2 0.54
F. carica (leaves) ME - - - - - - 12±0.8 - 13±0.7 16±0.3 17±0.4 0.53
EE 11±0.4 15±0.5 - 1.36 11±0.5 16±0.5 12±0.4 0.70 13±0.5 19±0.5 17±0.5 0.63
G. diversifolia (leaves) ME - 16±0.2 - - 12±0.3 16±0.4 12±0.5 0.67 15±0.5 19±0.4 16±0.3 0.61
EE - - - 13±0.6 16±0.4 13±0.3 0.62 12±0.4 17±0.4 16±0.6 0.61
M. neglecta (leaves) ME 14±0.3 16±0.4 - 1.14 15±0.3 16±0.4 13±0.5 0.57 14±0.4 18±0.3 17±0.4 0.58
EE 13±0.5 17±0.3 - 1.31 14±O.6 18±0.3 12±0.4 0.69 12±0.3 19±0.5 18±0.2 0.63
S. hexandrum (root) ME 12±0.4 15±0.3 - 1.25 12±0.5 14±0.5 13±0.4 0.56 14±0.5 18±0.3 18±0.4 0.56
EE 17±0.4 22±0.2 - 1.29 18±0.4 22±0.3 13±0.2 0.71 17±0.5 22±0.3 19±0.3 0.61
R. cordifolia (leaves) ME 12±0.3 13±0.4 - 1.08 13±0.3 16±0.3 14±0.4 0.59 14±0.4 17±0.2 17±0.4 0.55
EE 12±0.4 13±0.4 - 1.08 14±0.4 16±0.1 14±0.2 0.57 14±0.3 17±0.3 17±0.4 0.55
S.glaucophylum 
(whole plant)
ME 13±0.3 17±0.5 - 1.31 13±0.4 17±0.4 12±0.4 0.68 15±0.4 20±0.5 17±0.3 0.63
EE - 16±0.5 - - 13±0.4 16±0.1 12±0.3 0.64 12±0.5 17±0.3 17±0.5 0.59
V. jatamansi (root) ME 22±0.3 24±0.2 - 1.09 21±0.5 22±0.4 14±0.5 0.63 21±0.4 21±0.4 18±0.3 0.54
EE 14±0.3 21±0.3 - 1.50 17±0.4 21±0.3 14±0.3 0.68 17±0.3 22±0.3 18±0.2 0.63
Values given are mean of three replicates±SD. GIIs: Growth inhibitory indices, ME: Methanolic extract, EE: Ethyl acetate extract, PE: Plant extract, Nx: Norfloxacin, 
SD: Standard deviation, (-): No inhibition zone, A. glauca: Angelica glauca, D. hatagirea: Dactylorhiza hatagirea, F. carica: Ficus carica, G. diversifolia: Girardinia 
diversifolia, M. neglecta: Malva neglecta, S. hexandrum: Sinopodophyllum hexandrum, R. cordifolia: Rubia cordifolia, S. glaucophylum: Sedum glaucophylum, 
V. jatamansi: Valeriana jatamansi
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Fig. 1: Absorbance of plant extracts at 89 µM of berberine
Fig. 3: Effect of plant extracts on accumulation of ethidium bromide by 8325‑4 wild type strain
Fig. 2: Effect of plant extracts on accumulation of ethidium bromide by 2378 over expressing strain
the PEs selected on the basis of synergistic activity in the current study 
showed efflux pump inhibitory activity, but maximum activity exhibited 
by A. glauca (ME). Keeping the reference of the same, the present 
investigations results followed the Rana et al., 2014 [34], in which the 
plants Artemisia absinthium, Berberis plant, Geranium caespitosum, 
R. officinalis, Dalea versicolor, Lycopus europaeus, Thymus vulgaris, 
Jatropha elliptica, Piper nigrum, Piper longum, Salix alba, Momordica 
balsamina, Lupinus argenteus, Artemisia annua, Ipomoea murucoides, 
Herissantia tiubae, Mezoneuron benthamianum, and Securinega virosa 
exhibited NorA efflux pump inhibitory activity. Hence, the present 
investigations added an extra knowledge of efflux pump inhibitory 
activity for the tested plants collected from Western Himalayan region 
of India. The bioactive compounds having efflux inhibitory activity of A. 
glauca (ME) can be used in future as adjutants with antibiotics.
CONCLUSION
The above study can be concluded that the problem of antimicrobial 
resistance due to efflux is growing, and the outlook for the use of 
antimicrobial drugs against S. aureus in the future is still uncertain. 
The synergistic effect of the association of antibiotic with efflux 
pump inhibitors isolated from plant sources against S. aureus leads to 
new choices for the treatment of Staphylococcal diseases. This study 
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has shown that a ME of A. glauca exhibits potentials of synergy in 
combination with selected antibiotics against S. aureus strains, often 
presenting with problems of drug resistance (mainly due to efflux 
pumps). Moreover, this study established a good base for developing 
future, NorA efflux pump inhibitors from A. glauca (ME) as an adjuvant 
of antibiotics.
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